Substituted Heterocyclic Ethers and Their Use in CNS Disorders
申请人:Degnan Andrew P.
公开号:US20090018132A1
公开(公告)日:2009-01-15
The invention encompasses compounds of Formula I, including pharmaceutically acceptable salts, their pharmaceutical compositions, and their use in treating CNS disorders.
这项发明涵盖了公式I的化合物,包括药用盐、它们的药物组合物以及它们在治疗中枢神经系统疾病中的用途。
[EN] SUBSTITUTED HETEROCYCLIC ETHERS AND THEIR USE IN CNS DISORDERS<br/>[FR] ÉTHERS HÉTÉROCYCLIQUES SUBSTITUÉS ET LEUR UTILISATION DANS DES TROUBLES DU SYSTÈME NERVEUX CENTRAL
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2009009411A1
公开(公告)日:2009-01-15
The invention encompasses compounds of Formula (I), including pharmaceutically acceptable salts, their pharmaceutical compositions, and their use in treating CNS disorders.